The tyrosine phosphatase DEP-1 induces cytoskeletal rearrangements, aberrant cell-substratum interactions and a reduction in cell proliferation by Kellie, S. et al.
Introduction
Tyrosine phosphorylation is central to many aspects of cellular
responses to extracellular stimuli, including the transduction
of signals from the cell surface to the nucleus, new
gene expression, proliferation and cytoskeletal changes
(Schlessinger, 2000; Hubbard and Till, 2000). Protein-tyrosine
phosphatases (PTPs) act both as positive and negative
regulators of signal transduction and members of the PTP
family have essential functions in growth, differentiation and
related responses in different cell types (Östman and Böhmer,
2001; Andersen et al., 2001). For example, CD45 is essential
for the activation of the tyrosine kinase lck and downstream
signalling of the T cell receptor (Chen et al., 1996); the
intracellular PTP SHP-1 is a negative regulator of NK cell
signalling (Binstadt et al., 1996), and PTP1B has been
identified as a negative regulator of insulin signalling (Elchebly
et al., 1999). DEP-1 (also known as CD148, HPTPh, Byp
and rDEP-1) is a Class III receptor-like protein tyrosine
phosphatase (R-PTP), which contains a single intracellular
catalytic domain and a number of FNIII repeats in its
extracellular domain.
Its molecular mass varies (180-250 kDa) because of variable
glycosylation and it has been proposed to be a chondroitin
sulphate proteoglycan. DEP-1 is expressed throughout the
haematopoietic system and in a wide variety of tissues including
pancreas, thyroid, kidney, mammary gland and nervous system
(Autschbach et al., 1999; de la Fuente-Garcia, 1998). DEP-1 is
expressed at low levels in resting T cells, but is upregulated in
activated T cells, and ligation with anti-DEP-1 antibodies
induces proliferation of anti-CD3 activated T cells (Tangye et
al., 1998a). Interestingly, transient transfection of DEP-1 has
been reported to be a negative regulator of T cell activation, and
also results in a reduction of TCR-mediated ERK-1 and ERK-
2 activation, and reduced tyrosine phosphorylation (Palou et al.,
1997; Hundt et al., 1997; Tangye et al., 1998a; Tangye et al.,
1998b; Billard et al., 2000; del Pozo et al., 2000). DEP-1
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The receptor protein tyrosine phosphatase density-
enhanced phosphatase-1 (DEP-1) has been implicated in
aberrant cancer cell growth and immune cell function,
however, its function within cells has yet to be properly
elucidated. To investigate the cellular function of DEP-1,
stable cell lines inducibly expressing DEP-1 were
generated. Induction of DEP-1 expression was found to
decrease PDGF-stimulated tyrosine phosphorylation of a
number of cellular proteins including the PDGF receptor,
and to inhibit growth factor-stimulated phosphorylation of
components of the MAPK pathway, indicating that DEP-1
antagonised PDGF receptor signalling. This was supported
by data showing that DEP-1 expression resulted in a
reduction in cell proliferation. DEP-1-expressing cells had
fewer actin-containing microfilament bundles, reduced
vinculin and paxillin-containing adhesion plaques, and
were defective in interactions with fibronectin. Defective
cell-substratum adhesion correlated with lack of activation
of FAK in DEP-1-expressing cells. Time-lapse interference
reflection microscopy of live cells revealed that although
small focal contacts at the leading edge were generated in
DEP-1-expressing cells, they failed to mature into stable
focal adhesions, as found in control cells. Further motility
analysis revealed that DEP-1-expressing cells retained
limited random motility, but showed no chemotaxis
towards a gradient of PDGF. In addition, cell-cell contacts
were disrupted, with a change in the localisation of
cadherin from discrete areas of cell-cell contact to large
areas of membrane interaction, and there was a parallel
redistribution of b -catenin. These results demonstrate that
DEP-1 is a negative regulator of cell proliferation, cell-
substratum contacts, motility and chemotaxis in
fibroblasts.
Movies available on-line
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expression also inhibits TCR-mediated activation of ras and
calcium, and it has been reported that PLCg and LAT are
potential downstream targets for activated DEP-1 (Baker et al.,
2001). In the mouse, DEP-1 is expressed at highest levels in
macrophages; it is downregulated by CSF-1 and upregulated by
lipopolysaccharide (Osborne et al., 1998). Hence, DEP-1 may
be a regulator of macrophage growth and/or activation. 
In 3T3 fibroblasts, R-PTPase activity increases eightfold in
dense cultures compared with sparse cultures. The finding that
there is no change in PTPase activity in serum-starved cells and
that the increase in R-PTP activity can be demonstrated only in
contact inhibited cells grown to high density (Keane et al.,
1996) has led to the suggestion that R-PTPases may play a role
in contact inhibition of cell growth. DEP-1 expression has been
observed to increase dramatically in epithelial cells as they
become confluent and so it may represent a candidate molecule
for negative regulation of cell proliferation (Ostman et al., 1994;
Keane et al., 1996; Sorby et al., 1996). DEP-1 has recently been
shown to dephosphorylate the PDGF receptor, and thus is a
putative negative regulator of PDGF signaling (Kovalenko et al.,
2000; Persson et al., 2002). Holsinger et al. (Holsinger et al.,
2002) have shown an interaction between DEP-1 and p120ctn.
Recently DEP-1 has been mapped to colorectal tumour
susceptibility loci in mice and humans (Rivenkamp et al., 2002).
Despite these reports, there is still little data on the function
of DEP-1 in cells, and its natural ligand is unknown. Since
previous attempts to generate stable DEP-1-overexpressing cell
lines have been unsuccessful, we have chosen to investigate the
functional consequences of DEP-1 overexpression using
inducible cell lines. In this paper we describe DEP-1-mediated
changes in cell proliferation, adhesion, motility and cytoskeletal
reorganization in NIH 3T3 cells.
Materials and Methods
Cell culture 
Unless otherwise stated, all cell lines were obtained from the
American Type Culture Collection and maintained at 37°C in a
humidified 5% CO2 incubator. NIH3T3 cells were grown in
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum, 2 mM L glutamine, 100 units/ml penicillin, and 100
mg of streptomycin (Life Technologies, Inc.). 
Cloning of DEP-1 and generation of inducible cell lines
Full-length human DEP-1 gene was cloned by PCR from MCF7 cells
and ligated into pGeneV5/His inducible expression vector
(Invitrogen) as described by the manufacturer. This was then
transfected into pSwitch-containing stable NIH3T3 cells (Invitrogen)
using Lipofectamin 2000 (Invitrogen) and further stable cell lines
were isolated by selection in 400 m g/ml zeocin as described by the
manufacturer. Three clones are described in this report: 1A2, a control
clone that contains an empty pGene vector, and clones 2C2 and 2D3
that express full-length DEP-1 when treated with mifepristone.
Preliminary dose response and time course experiments indicated that
treatment with 1 nM mifepristone for 3 hours then washing out gave
optimal DEP-1 expression with no apparent nonspecific effects on
cells. Protein expression was assessed by immunofluorescence or
western blotting 24-48 hours after induction.
Western blotting and immunoprecipitation
Uninduced cells or cells induced for 24 hours were quiesced for 4
hours in serum-free medium, then stimulated with 50 ng/ml PDGF for
10 minutes. In some cases 1 m M LY294002 was added as a PI 3-kinase
inhibitor. Cells were washed three times in ice-cold Tris-buffered
saline and solubilised in Laemmli sample buffer. 10% denaturing
SDS-PAGE-separated proteins from 105 cells were transferred to
nitrocellulose filters (Schleicher and Schuell, Dassell, Germany) and,
after blocking with 5% non-fat dried milk for 1 hour, the filters were
overlaid with a 1:1000 dilution of anti-V5 (Sigma) containing 0.05%
Tween 20 for 1 hour. The filters were washed three times in
PBS/Tween 20 and overlaid with a peroxidase-conjugated goat anti-
mouse Ig (Bio-Rad). The bands were detected using the ECL system
(Amersham Pharmacia Biotech). Other primary antibodies used were
anti-PDGF receptor (Upstate Biotechnology, Lake Placid, NY),
anti-cadherin (Sigma), anti-phosphotyrosine 4G10 (Upstate
Biotechnology, Lake Placid, NY), anti-phospho-ERK and anti-
phosphoAkt (New England Biolabs, Hitchin UK) and anti-FAK
(Sigma). Immune precipitation was performed as previously
described (Wilson et al., 1995). Briefly, 107 cells were resuspended in
1 ml RIPA buffer (Tris-buffered saline pH 7.2, 1% Nonidet P40, 1%
sodium deoxycholate, 1 mM EDTA, 100 mM sodium orthovanadate)
and protease inhibitor cocktail at 100 m l per 107 cells) and gently
mixed on a rotator at 4°C for 20 minutes. The lysate was precleared
with 50 ml of a 50% slurry of agarose-conjugated protein-A/G and
incubated on a rotator at 4°C for 45 minutes. Anti-PDGF receptor (5
m l/ml; Upstate Biotechnology) was added to the precleared cell lysate
and incubated on a rotator at 4°C for 2 hours. 40 m l of a 50% slurry
of protein-A agarose was added and incubated for 1 hour at 4°C on a
rotator. Immunocomplex bound to protein-A/G agarose was then
collected by pulse centrifugation for 5 seconds at 11,000 g and washed
three times with ice-cold RIPA buffer, followed by resuspension in 60
m l of 2· SDS sample buffer and heating to 100°C for 5 minutes.
Samples were centrifuged at 11,000 g to remove the beads, and
supernatants were separated by SDS-PAGE. FAK immune
precipitation and western blotting was performed as previously
described (Wilson et al., 1995).
Immunocytochemistry and fluorescence microscopy 
BrdU incorporation was measured essentially as previously described
(Murray et al., 2000) with the following modifications. 2 · 104 cells
were plated on to coverslips in the bottom of 24-well plates in the
presence or absence of 1 nM mifepristine. 16 hours later the cells were
quiesced for 4 hours in serum-free medium. Cells were then
stimulated by the addition of 50 ng/ml PDGF in 0.1% FCS for 18
hours, with 10 m M BrdU labelling reagent (Roche BrdU detection kit
1) being added for the final hour. Staining for BrdU was performed
as described by the manufacturer. NIH3T3 cells were plated onto acid-
washed glass coverslips at 50% confluence and incubated overnight.
Cells were washed for 5 minutes in phosphate-buffered saline; PBS)
and then fixed in 4% paraformaldehyde in PBS for 20 minutes. After
a further 5-minute wash in PBS, cells were incubated in PBS, 10%
normal goat serum (NGS) and 0.2% Triton X-100 for 30 minutes. The
cells were then incubated overnight at 4°C with murine monoclonal
antibodies against V5, paxillin, vinculin, tubulin, cadherin or catenin
(Sigma), each diluted 1: 500 in PBS and 1% NGS. Cells were washed
four times for 5 minutes in PBS, 10% NGS and 0.2% Triton X-100
before Alexa 488-conjugated goat anti-mouse antibody (Molecular
Probes) was applied at 1:200 dilution in PBS and 1% NGS for 1 hour.
After four additional 5-minute washes in PBS, 10% NGS and 0.2%
Triton X-100, the cells were immersed briefly in distilled water and
mounted in S3023 fluorescent mounting medium (Dako). In some
cases, F-actin was localised by treating the cells with a 1:500 dilution
of Rhodamine phalloidin (Sigma). Cells were viewed using an
Axiovert 135 microscope (Zeiss) coupled to a monochrome light
source (Photonics Polychrome II). A series of optical scans through
the z axis of the cells were captured using a Hamamatsu digital
camera, and image deconvolution was performed with Openlab
software (Improvision). 
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Cell attachment and spreading on fibronectin
Acid-treated coverslips were treated with 0.05 mg/ml bovine plasma
fibronectin (Sigma) overnight at 4°C, washed twice in PBS and placed
in 24-multiwell dishes. 5 · 104 cells were plated in serum-free DMEM
and incubated at 37°C for 1 hour or 3 hours as indicated (Wilson et
al., 1995). Living cells were photographed and the number of attached
or spread cells per field of view under · 20 objective lens
magnification were counted. Spread cells were defined as those cells
that had lost their phase bright appearance and had readily
distinguishable nucleus and cytoplasm. 
Interference reflection microscopy
Interference reflection images were collected using a Zeiss Standard
18 microscope with an incident light fluorescence attachment housed
in a constant temperature room set at 37°C. Exciter and barrier filters
were removed from the LP420 reflector and replaced with a narrow
band pass filter to isolate the 546 nm line of the mercury arc source.
Coverslips with attached cells were placed onto glass chambers,
sealed with wax and observed using a Zeiss 63 · Neofluar Antiflex oil
immersion objective, NA 1.25. In some experiments, images were
collected every second for a period of 10 minutes. For long-term
studies, images were collected at 60-second intervals for up to 1 hour.
Time-lapse images were collected digitally using in-house software.
Single frame TIFF images were extracted from TIFF stacks using a
routine written in Mathematica 4.2. Images were processed. Briefly,
overlay methods were used to summate the intensities of the black
zones (focal adhesions) at the leading edges of selected fibroblasts as
measured in pixels. To counteract the effects of cell migration,
quantification of the lifetime of individual pixels was performed on
four images collected at 10-minute intervals. By appropriate
manipulation of grey levels (0, black; 63, dark grey; 127, medium
grey, and 191, light grey), a composite image can be generated that
spans the four binned images. Black pixels represent pixels which
were occupied in all four images, dark grey pixels were present in
three out of four frames, medium grey two out of four frames, and
light grey pixels were only present in one frame. Black pixels
therefore reflect regions of low adhesion turnover, whereas light grey
pixels represent regions of high adhesion turnover. We have defined
a persistence index, where the percentage of pixels present in just one
or two of the four images are divided by the percentage present in
three or four images. Such procedures can be shown graphically
(Fig. 7B) to demonstrate the effective turnover rate of cell-matrix
adhesions; the lower the value of the persistence index, the less stable
the adhesions (M. Holt, University College London, UK and G. E.
Jones, unpublished).
Chemotaxis assays
Chemotaxis was assessed by direct observation and recording of cell
behaviour in stable concentration gradients of PDGF using the Dunn
chamber chemotaxis chamber (Weber Scientific International;
Division of Hawksley Technology; www.hawksley.co.uk). This
apparatus permits speed, direction of migration and displacement of
individual cells to be measured in relation to the direction of a
diffusible gradient (Zicha et al., 1991). Details of the construction and
calibration of Dunn chambers can be found elsewhere (Allen et al.,
1998; Jones et al., 2000). The chamber was filled with medium and a
coverslip (previously seeded with cells and subject to appropriate
experimental manipulation to induce DEP-1 expression where
required) was inverted and sealed onto the chamber. Medium
containing PDGF at a concentration of 60 ng/ml was placed into the
outer well of the chamber. Chambers were maintained at 37°C and
frame grabbing time-lapse recording of cells located on the bridge of
the Dunn chamber was started within 30 minutes of assembly. Images
of cells were digitally recorded at a time-lapse interval of 10 minutes
for 6 hours using Kinetic Imaging AQM System (Kinetic Imaging plc,
Bromborough UK, www.kineticimaging.com). Cells were tracked and
analysed as described previously (Allen et al., 1998; Sturge et al.,
2002). Briefly, cell tracks were generated from the time-lapse images
using the image-processing program Lucida (also from Kinetic
Imaging), and the resulting tracks were tested for directional bias
using the Rayleigh test for unimodal clustering of directions (Jones et
al., 2000; Mardia, 1972) using customised notebooks written in
Mathematica™ for Windows (Wolfram Research Inc., Champaign,
IL, USA). Horizon plots generated by the Mathematic notebook are
displayed as circular histograms, such that if statistically significant
unimodal clustering of cell trajectories is found, a mean direction
(arrow) and the 95% confidence interval for the data set (grey
segment) are automatically generated and displayed. Cells that
translocated less than 20 m m from their point of origin (the horizon
boundary) were excluded from this analysis.
Results
Inducible expression of DEP-1 in 3T3 cells
Repeated attempts to generate stable transfectants of DEP-1
failed because of a lack of long term growth in selection
medium. As an alternative strategy, DEP-1 was cloned into
pGene vector and this construct was transfected into NIH3T3
cells expressing the pSwitch vector. Clones were then selected
and screened for the expression of DEP-1 induced by
mifepristone. Fig. 1 shows examples of these clones. 1A2 is a
clone of pSwitch 3T3 control cells transfected with empty
pGene vector. This clone showed no expression of DEP-1 in
the presence or absence of mifepristone. In contrast, clones
2C2 and 2D3 showed inducible expression of DEP-1 after
mifepristone treatment. The induced DEP-1 was localized
mainly to the plasma membrane with some endoplasmic
reticulum staining, as expected for a transmembrane
polypeptide (Fig. 1, upper panels). Western blotting confirmed
that the mifepristone-induced DEP-1 was expressed at the
expected size for the full-length protein (Fig. 1 lower panel).
Mifepristone had no effect on levels of endogenous DEP-1 in
NIH3T3 cells as assessed by real time PCR (data not shown).
DEP-1 effects on cell proliferation
Cultures of DEP-1-expressing cells appeared to grow to lower
densities than control cells (data not shown). To investigate this
in more detail the effect of DEP-1 on cell proliferation was
assayed using BrdU uptake. Control 1A2 cells showed the
same level of BrdU uptake in the presence or absence of
mifepristone (Fig. 2), with 33% of the cells showing nuclear
BrdU under normal culture conditions. However, whilst 2D3
cells in the absence of mifepristone displayed a similar level
of BrdU incorporation, induction of DEP-1 with mifespristone
significantly reduced the number of cells incorporating BrdU,
from 32% to 8% of the population (Fig. 2). Thus DEP-1-
expression significantly reduced the number of cells entering
S phase.
Growth factor signalling
To examine in more detail the role of DEP-1 in growth
inhibition, the effects of DEP-1 expression on the PDGF-
dependent signalling events were examined. Initial
experiments were performed to confirm the activity of
expressed DEP-1 in NIH 3T3 cells. Cells were quiesced and
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then stimulated with PDGF for 10 minutes. Phosphotyrosine
blotting of whole cell lysates from quiesced or PDGF-
stimulated cells demonstrated that the PDGF-stimulated
increases in tyrosine phosphorylated polypeptides was
suppressed in DEP-1-expressing cells (Fig. 3A).
Immunoprecipitation confirmed the lack of ligand-induced
tyrosine phosphorylation of the PDGF receptor in DEP-1-
expressing cells (Fig. 3B). The role of DEP-1 in receptor
signalling was further examined by investigating the
association of c-src with the activated PDGF receptor. In
unstimulated 1A2 control cells there was minimal association
of c-src with PDGF receptor, however, after PDGF ligation c-
src co-immunoprecipitated with the PDGF receptor (Fig. 3C).
Mifepristone treatment had no effect on this response.
Uninduced 2D3 cells displayed similar c-src association with
activated PDGF receptor, but when DEP-1 was induced the
association of c-src with activated PDGF receptor was ablated
(Fig. 3C).
Quiescent 1A2 control cells showed the expected
appearance of phosphorylated p42/p44 MAPK when
stimulated with 50 ng/ml PDGF, and mifepristone had no
effect on this, although it was inhibited as expected by the
PI 3-kinase inhibitor LY294002 (Fig. 4A). In the absence
of mifepristone, 2C2 and 2D3 cells also showed PDGF-
dependent phosphorylation of p42/p44 MAPK. However,
when these cells were induced to express DEP-1 the PDGF-
dependent phosphorylation of p42/p44 MAPK was markedly
reduced (Fig. 4A). Similarly, the appearance of phospho-Akt
after PDGF simulation was not affected by mifepristone
in 1A2 cells, but phospho-Akt generation was abolished
by DEP-1 induction in 2D3 cells (Fig. 4B). These data
suggest that DEP-1 inhibits cell growth by interfering with
the ras-MAPK pathway and also the PI3-kinase-Akt pathway,
leading to a reduction in proliferation and perhaps also
cell survival. 2c2 cells showed similar responses to 2D3
cells.
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Fig. 1. Inducible expression of DEP-1 protein in NIH3T3 cells. (A) Immunofluorescent
staining for DEP-1 in untreated or mifepristone-treated cells showing prominent plasma
membrane and some ER localization. (B) Western blotting of DEP-1 in NIH3T3 cells
showing full-length protein production. Scale bar: 10 m m.
Fig. 2. DEP-1 expression causes cell cycle
arrest. (A) Quantification of BrdU uptake in
NIH3T3 cells. (B) Immunofluorescent staining
for BrdU in 2D3 NIH3T3 cells (left) or 2D3
cells induced to express DEP-1 (right). Scale
bar: 10 m m.
Fig. 3. DEP-1 expression reduces PDGF-induced tyrosine
phosphorylation. Cells were quiesced for 4 hours then
stimulated with 50 ng/ml PDGF. (A) Western blotting of
whole cell lysates from PDGF-stimulated control 1A2 cells
or DEP-1-expressing 2D3 cells with antiphosphotyrosine.
(B) Western blotting of PDGF receptor immune precipitates
with antiphosphotyrosine. (C) Association of c-src with
PDGFR in DEP-1-expressing cells. DEP-1 expression
reduces c-src association with PDGFR. Uninduced and
induced NIH3T3 cells were stimulated with PDGF as
described in Materials and Methods. PDGF receptor was
immune precipitated and immunoblotted for c-src (upper
panel) or PDGF (lower panel).
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Cell-substratum interactions in DEP-1-expressing cells
The effects of DEP-1 expression on cell motility were
examined by digital time-lapse photomicrography. Control
1A2 cells, in the presence of mifepristone, spread and polarised
normally on tissue culture plastic. These cells showed the
expected features of fibroblast motility including normal
lamellipodia formation during polarised cell spreading (Fig.
5A). In contrast, mifepristone-treated 2C2 cells were much
more rounded and showed a more random complex phenotype.
The cells appeared to be tethered at one edge, which would
periodically be released, resulting in intervals of relatively little
vectoral movement followed by a sudden large jump of several
microns (Fig. 5A; this is best seen in the accompanying
movie, Movie 1, http://jcs.biologists.org.supplemental). The
interactions of cells with a defined substratum was studied by
quantifying the extent of cell spreading on fibronectin. Control
1A2 cells in the presence of mifepristone showed normal
adhesion and spreading (defined by the lack of phase-bright
cells as described in Materials and Methods), with
progressively more cells adhering and spreading after 1 hour
and 3 hours respectively. 2D3 cells expressing DEP-1 showed
a lower number adherent cells and spread cells, only 50-60%
that of control cells at both 1 hour and 3 hours (Fig. 5B). Unless
otherwise stated, in all experiments uninduced 2D3 and 2C2
cells showed identical responses to uninduced 1A2 cells. FAK
activation is a major downstream response to fibronectin
adhesion, therefore tyrosine phosphorylation of FAK was
investigated in DEP-1-expressing cells. Unstimulated control
1A2 cells showed only low/basal levels of FAK tyrosine
phosphorylation in suspension. This increased dramatically
after plating onto fibronectin (Fig. 5C) and was unaffected by
mifepristone treatment. A similar pattern of FAK tyrosine
phosphorylation was found in uninduced 2D3 cells. However,
when DEP-1 was induced these cells showed a substantially
reduced level of FAK tyrosine phosphorylation compared with
1A2 cells after plating on to fibronectin (Fig. 5C). These results
indicate that both c-src-mediated signalling and FAK-mediated
cytoskeletal events may be regulated by DEP-1.
Cytoskeletal changes associated with DEP-1 expression
Aberrant adhesion and spreading on fibronectin suggested
cytoskeletal defects in DEP-1-expressing cells, so the
organisation of the cytoskeletal proteins F-actin, tubulin,
vinculin and paxillin was investigated. Uninduced cells
displayed well-formed F-actin containing microfilament
bundles within the cytoplasm and under the plama membrane.
However, cells expressing DEP-1 were smaller, more rounded
and contained few, if any, microfilament bundles (Fig. 6 top
row). These cells also contained brightly-staining F-actin
aggregates. DEP-1 expression also resulted in aberrant
microtubule organisation. Whilst uninduced or control cells
had well-developed microtubule networks, extending to the
periphery of the cell, cells expressing DEP-1 had a less
extensive microtubule netrwork, with fewer microtubules.
These cells commonly contained perinuclear condensations
of disorganised microtubule bundles (Fig. 6 second row).
DEP-1 expression also resulted in a decrease in focal
adhesion formation as assessed by paxillin and vinculin
staining. Uninduced cells displayed a large number of
prominent paxillin or vinculin-containing focal adhesions at
the cell periphery (Fig. 6 third and fourth rows). After 48
hours of DEP-1 expression, there were virtually no paxillin-
containing focal contacts in the 2C2 or 2D3 cells although
they were present in the control, mifepristone-treated 1A2
cells (Fig. 6). 
Focal adhesions in DEP-1-expressing cells
The observation that there were fewer vinculin and paxillin-
containing focal adhesions in DEP-1-expressing cells (Fig. 6),
suggested that this was the structural basis underlying the
defective cell interaction with substrata such as fibronectin
(Fig. 5B). Interference reflection microscopy of living cells
revealed that cells in which DEP-1 was induced had aberrant
substratum adhesions. Whilst the control cells were able to
generate well-defined, stable focal contacts with associated
stress fibres, adhesions in the DEP-1-expressing cells remained
as more dot-like peripheral structures (Fig. 7A) reminiscent of
focal complexes (Small, 2002). Quantification of the turnover
of adhesions as a persistence index (Fig. 7B) confirmed that
these attachments were transient and did not stabilise into
mature focal adhesions.
DEP-1 results in defective chemotaxis
Fibroblasts have the ability to sense gradients of PDGF and
Fig. 4. DEP-1 expression reduces PDGF-induced MAP kinase and
Akt phosphorylation. (A) Western blotting of NIH3T3-DEP-1 cells
for phospho p42/p44 MAPK after quiescence and stimulation with
PDGF. (B) Western blotting of NIH3T3-DEP-1 cells for phospho-akt
after quiescence and stimulation with PDGF.
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Fig. 5. DEP-1-expressing cells exhibit
defective motility and interaction with
fibronectin. (A) Parallel cultures of 1A2 and
2D3 cells imaged at 1-hour intervals over 6
hours showing lack of cell spreading in DEP-
1-expressing 2D3 cells. (B) Quantification of
cell adhesion and spreading on a fibronectin
substratum. Cells were plated on to
fibronectin-coated coverslips and washed
after either 1 hour or 3 hours, as indicated,
before fixation and counting. (C) Tyrosine
phosphorylation of FAK. Cells were plated
on fibronectin (FN plating +) or held in
suspension (FN plating –). Lysates were
immunoprecipitated with anti-FAK antibody
followed by immunoblotting with anti-
phosphotyrosine (upper panel) or ant-FAK
(lower panel). 
Fig. 6. Localization of cytoskeletal proteins in DEP-1-expressing cells. Control 1A2, or DEP-1-expressing 2C2 or 2D3 cells were induced with
mifepristone for 24 hours, plated on to coverslips and stained for F-actin, tubulin, vinculin or paxillin as described in Materials and Methods.
All of the DEP-1-expressing cells showed disruption of microfilament bundles, microtubules and adhesion plaques. Scale bar: 10 m m
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migrate chemotactically towards the gradient source. Since
proliferation in response to PDGF was diminished in DEP-1-
expressing cells, we investigated whether PDGF-induced
migration was also affected. Mifepristone-treated control
1A2 or DEP-1-expressing 2D3 cells were assembled on a
Dunn chamber and PDGF was infused from the periphery
to generate a gradient. The cells were then studied using
time-lapse photography as described in Materials and
Methods. 1A2 cells initially showed stimulated membrane
ruffling and lamellipodia formation, followed by directed
locomotion towards the gradient source. In contrast, 2C2 cells
showed little stimulation of membrane activity and no
directed locomotion up the PDGF gradient. Time-lapse
images of the two cell types are shown in Fig. 8A, where the
image interval is 10 minutes. Fig. 8B presents the Raleigh test
for directional migration (Jones et al., 2000) that shows
significant chemotaxis of control 1A2 cells towards PDGF.
The migratory abilities of the DEP-1-expressing 2C2 cells
was severely compromised, and 25 cells passing beyond
the 20 m m horizon did not show any preferential directional
bias.
Changes in cell-cell interactions associated with DEP-1
expression
DEP-1 induction resulted in 3T3 cells tendending to clump
together, rather than attach to the tissue culture surface.
Although this might be due to altered substratum adhesions or
actin cytoskeleton (Figs 5 and 6), it is possible that other
mechanisms might also be disrupted by DEP-1. Candidate
molecules that DEP-1 might deregulate are cadherins, which
are involved in intercellular interactions.
Cadherin staining in mifepristone-treated 1A2
cells showed typical concentration at cell-cell
contacts where plasma membranes intercalate.
In these contacts the cadherin had a speckled
distribution at the two interposing membranes
and co-localised with high F-actin
concentrations (Fig. 9, arrows). Other areas of
the membranes not involved in cell-cell
contact exhibited lower cadherin staining
levels (Fig. 9). Cadherin staining in
mifepristone-treated, DEP-1-expressing 2D3
cells, however, showed an altered localization.
Whilst there was no evidence for intercalation
of plasma membranes, there was strong
cadherin staining along the plasma membranes
of the clumped cells. Strong staining was also
observed in areas of the membrane not in
contact with other cells (Fig. 9 arrowhead).
Western blotting showed no changes in the
amount of cadherin in the cells (data not
shown). b -catenin staining mimicked that of
cadherin staining (Fig. 10). In the control 1A2
cells b -catenin staining appeared at discrete
cell-cell junctions and areas of interposing
membranes. However, in the DEP-1-
expressing cells there was extensive staining
along the cell peripheries where the DEP-1-
expressing membranes were in contact (Fig.
10).
Fig. 7. Defective turnover of focal contacts in DEP-1-expressing
cells. (A) Large well-developed focal contacts can be seen at the
leading edge of control fibroblasts. DEP-1 expression results in cells
that generate only small focal adhesions, possibly focal complexes,
at the very margins of the leading lamellipodium. (B) The unstable
nature of these adhesions was quantified as described and is shown as
a persistence index in which a high persistence directly equates to
stability of the adhesions. Mean persistence index ± s.e.m.; Student’s
paired t-test shows no significant differences between 1A2 cells plus
or minus treatment with mifepristone, and P<0.01 between control
2D3 cells and 2D3 plus mifepristone.
Fig. 8. Aberrant chemotaxis in DEP-1-expressing NIH3T3 cells. Cells were placed in
Dunn chambers and a gradient of PGDF introduced. Cell motility was recorded by
time-lapse videomicroscopy. (A) Parallel cultures of control 1A2 and DEP-1-expressing
2D3 cells imaged at 10-minute intervals for the first 60 minutes of a 6-hour chemotaxis
assay. 1A2 cells migrate up the PDGF gradient, while 2D3 cells do not. (B) Horizon
plots of 1A2 and 2D3 cell populations analysed for directional migration over the full 6-
hour period of the assay. Significant unimodal clustering of cell directions is seen in the
1A2 population (arrow plus 95% confidence limit). As the mean direction of cell
movement is upward, we conclude that 1A2 cells show positive chemotaxis to a source
of PDGF (n=25 cells, taken from three separate experiments in each case).
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Discussion
Ostman et al. (Ostman et al., 1994) originally reported that
DEP-1 expression in epithelial cells correlated with a loss of
proliferative capacity. Subsequently, DEP-1 expression has
been shown to inhibit cancer cell growth, to dephosphorylate
the PDGF receptor and to associate with p120ctn in different cell
types (Keane et al., 1996; Kovalenko et al., 2000; Holsinger et
al., 2002). We found that inducible DEP-1 expression in
fibroblasts leads to decreases in proliferation concurrent with
defective cell-substratum contacts, FAK phosphorylation
and cadherin distribution. Cell proliferation experiments
demonstrated that ectopic expression of DEP-1 in NIH3T3 cells
caused cell cycle arrest, with a dramatic reduction in the
population of cells in the synthetic phase of the cell cycle under
normal growth conditions. Previous attempts to generate stable
cell lines overexpressing DEP-1 had failed because of a lack of
growth in selection media, and it seems reasonable to conclude
that the reason for this was failure of the DEP-1-expressing cells
to proliferate. To further investigate the role of DEP-1 in
proliferation responses, cells were made quiescent and then
stimulated with PDGF. Whilst mifepristone-treated control cells
showed increased cellular tyrosine phosphorylation in response
to PDGF, mifepristone-induced DEP-1 cells showed no such
increases. Ligand-induced PDGF receptor phosphorylation was
also substantially reduced in DEP-1-expressing cells. This
supports previous reports that the PDGF receptor is a substrate
for DEP-1 (Kovalenko et al., 2000; Persson et al., 2002). Since
ligand-induced PDGF receptor phosphorylation was prevented
in DEP-1-overexpressing cells, it is probable that downstream
signalling events controlled by this would be inhibited. Reduced
tyrosine phosphorylation of PDGF in DEP-1-expressing cells
was consistent with a failure of c-src to associate with the
activated PDGF receptor, implying that the c-src recognition
site was dephosphorylated by DEP-1. Cells expressing DEP-1
also showed a reduction in phosphorylation of p42/44 MAPK
and akt/PKB. These results indicate that DEP-1 antagonizes the
PDGF receptor kinase activity and prevents signalling through
the c-src, ras-MAPK and PI 3-kinase-Akt pathways at the level
of receptor activation. It is probable that increased DEP-1
expression and activity is responsible for the reduction in
proliferation, rather than cell-cell contact per se, as under the
subconfluent conditions applied here only a small proportion of
the cells were in cell-cell contact.
Overexpression of DEP-1 in 3T3 cells resulted in distinct
morphological changes, with cells being more rounded and
phase-bright. To define this observation in more detail, cell
adhesion and spreading on a fibronectin substratum was
quantified, with DEP-1-expressing cells showing a significant
reduction in the ability to both adhere and spread.
Immunofluorescence showed that F-actin-containing stress
fibres were reduced in DEP-1-expressing cells, with a
concomitant increase in F-actin at the cell membrane, and
gross changes to the microtubule-based cytoskeleton. We do
not know as yet whether the alteration in microtubule
organisation is a direct consequence of actin fibre dissolution
or is an independent variable of DEP-1 expression. There was
also a reduction in vinculin and paxillin-containing focal
adhesions. IRM experiments on living cells showed that these
abnormalities were due to the inability of punctate focal
adhesions in DEP-1-expressing cells to mature into larger,
stable adhesion plaques (focal contacts). There is some
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Fig. 10. Cell islands overexpressing DEP-1 accumulate b -catenin at
the cell membrane. Control 1A2 cells or 2D3 DEP-1-expressing cells
were induced with mifepristone and stained for b -catenin. Staining
for b -catenin closely paralled that of cadherin, with uninduced cells
showing discrete foci of staining at cell-cell junctions and areas of
membrane intercalation (arrows). DEP-1 expressing cells showed
distinct b -catenin staining along the length of the plasma membrane.
Scale bar: 10 m m.
Fig. 9. Cell islands overexpressing DEP-1
have enhanced plasma membrane staining
for cadherin. Control cells or DEP-1 cells
were induced with mifepristone and double
stained for cadherin (upper panels) and F-
actin (lower panels). Uninduced cells show
discrete cadherin staining at cell-cell
contacts with little staining on the rest of the
plasma membrane (arrows), whereas DEP-
1-expressing cells show distinct staining
along large areas of the membrane
(arrowhead). Scale bar: 10 m m.
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evidence that stress fibres condense on focal adhesion
assemblies, and so the lack of stress fibres in DEP-1-positive
cells may be a result of the failure of focal complexes to mature
into focal contacts. Tyrosine phosphorylation of FAK was
dramatically reduced in DEP-1-expressing cells, and this may
be one mechanism by which these cells fail to produce mature
focal contacts, since phosphorylation of FAK and p130cas is
essential for focal adhesion assembly and turnover. In support
of this, p130cas has recently been shown to be a substrate of
the DEP-1-related phosphatase SAP-1 (Noguchi et al., 2001).
DEP-1-expressing cells also failed to show a normal
chemotactic response towards a PDGF source. It may be that
this defective migration is also due to failure in cell substratum
adhesions, although time-lapse videos showed that these cells
frequently failed to extend initial lamellipodia in the direction
of the gradient, suggesting a primary defect in gradient sensing
and response, a cell polarisation property intimately linked to
PI 3-kinase-mediated transduction pathways (Wang et al.,
2002; Weiner et al., 2002; Funamoto et al., 2002; Comer et al.,
2002). We have shown that at least one PI 3-kinase pathway
(activation of Akt) is inhibited by DEP-1 expression, and
further work should clarify the role of DEP-1 in modulating
directed cell translocation. GLEPP-1 (a member of the DEP-1
subfamily) overexpression in macrophages also results in
disruption of focal contacts and cytoskeletal components
(Pixley et al., 2001). FAK activation is a common point of
convergence between growth factors and substratum adhesion
and thus may be a major substrate for DEP-1 that regulates
both these events. 
Surprisingly, DEP-1 expression enhanced cell-cell adhesion.
This appeared to be not just the result of decreased cell-
substratum adhesion, but of a defined molecular mechanism.
In control cells, cell-cell contacts occurred at small discrete
areas of the plasma membrane and these stained strongly for
cadherin where the plasma membranes intercalated, with much
lower levels observed in other areas of the plasma membrane.
In contrast, DEP-1-expressing cells clustered together and
displayed extended contacts, which stained strongly for
cadherin over large areas of the plasma membrane. These data
are consistent with an increase in the adherens junction
structure(s) in DEP-1-expressing cells such that the
intercellular contacts are more reminiscent of the continuous
adherens junctions found in epithelial cells. Thus
overexpression of DEP-1 may result in increased organisation
of cell-cell junctions. Although we cannot formally
differentiate between cause and effect of increased cadherin
and increased cell clustering, the increased staining of cadherin
occurred in areas of the plasma membrane not in contact with
other cells, thus increased cadherin at the plasma membrane is
independent of intercellular cadherin clustering. Holsinger et
al. (Holsinger et al., 2002) have shown that DEP-1 associated
with p120ctn in A431 epithelial carcinoma cells, and our results
are in broad agreement with Lampugnani et al. (Lampugnani
et al., 2003) who reported that contact inhibition of VEGF-
induced proliferation requires DEP-1 as well as endothelial
cadherin and b -catenin. RPTPm has also been shown to
dephosphorylate p120ctn, so it is possible that different
members of the PTP family have overlapping functions
(Zondag et al., 2000). Whilst our results indicate that the PDGF
receptor is a direct substrate for DEP-1, it is possible that the
antiproliferative effects seen are an indirect consequence of
b -catenin translocation. For example, there was also an
increase in the intensity of membrane staining for b -catenin,
suggesting that increased membrane cadherin recruited b -
catenins, and thus could be part of a signalling complex. If b -
catenins were sequestered to the plasma membrane then there
would be a reduction in the pool of these molecules available
for cytoplasmic-nuclear translocation, and therefore a
reduction in b -catenin-associated transcription factor activity.
This in turn could downregulate the proliferative activity of the
cells. Several other PTPs such as LAR and PTP m /k have also
been implicated in cadherin and b -catenin regulation (Aicher
et al., 1997; Kypta et al.., 1996; Brady-Kalnay et al., 1995;
Fuches et al., 1996), and recently PTP a has been shown to
regulate integrin-stimulated FAK autophosphorylation and
cytoskeletal rearrangements (Zeng et al., 2003).
It is now apparent that PTPs can have specific and selective
roles in cell regulation. Although some PTPs such as PTPa and
CD45 have positive roles, the majority appear to have negative
regulatory roles in cell function (Andersen et al., 2001). This
is perhaps best exemplified by PTP1B, which is a negative
regulator of insulin receptor signalling; indeed PTP1B
inhibitors are in various phases of clinical trials as antidiabetic
therapeutics (Johnson et al., 2002). Other examples of
antagonistic effects towards growth factors include SHP-2,
LAR, PTPs , TCPTP (Klinghoffer and Kazlauskas, 1995; Kulas
et al., 1996; Suares-Pestana et al., 1999; Tiganis et al., 1998;
Koslowski et al., 1998). DEP-1 appears to belong to a subfamily
that controls tyrosine kinase receptor-mediated cellular
proliferation and cytoskeletal regulation, and thus is a crucial
molecule for many growth factor-mediated cellular responses.
We thank Jane Clarkson and Ming Chang for helpful advice on
gene expression analysis and western blotting. This work was partly
funded by a grant from University of Queensland and the CRC for
Chronic inflammatory diseases.
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